Skip to main content
. 2016 Jun 29;12(2):1361–1366. doi: 10.3892/ol.2016.4800

Figure 2.

Figure 2.

ROC analysis of the sensitivity and specificity of the levels of plasma MALAT1 in distinguishing DM/EOC from NDM/EOC and HC patients. The levels of plasma MALAT1 in the DM/EOC (n=47), NDM/EOC (n=47) and HC (n=47) groups were subjected to ROC analyses. The ROC-AUC for the levels of plasma MALAT1 to distinguish EOC/DM patients from EOC/NDM patients or HC individuals was 0.820 and 0.884, respectively (P<0.001). MALAT1, metastasis-associated lung adenocarcinoma transcript 1; EOC, epithelial ovarian cancer; EOC/DM, EOC with metastasis; EOC/NDM, EOC without metastasis; HC, healthy controls; AUC, area under the curve; ROC, receiver operating characteristic.